drugset / Trial / NCT00997477

Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics

NCT00997477

Phase 4 Withdrawn Novartis Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the correct use of sequential formoterol and budesonide inhaler capsule treatment via Aerolizer and patient satisfaction in adult asthmatics.

Timeline

Start
2010-06
Primary completion
2010-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule Inhaled
Subject Formoterol Other / unclassified Inhaled

Indications